Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (231-240 of 369) with videos related to

Pageof 37
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumorsO M El-Badry, C Minniti, E C Kohn, et al.
Cancer Research|February 15, 1994
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAIE C Kohn, C C Felder, W Jacobs, et al.
Proteomics|January 15, 2002
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancerMonica Brown Jones, Henry Krutzsch, Hungjun Shu, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Cancer|April 22, 2005
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinomaEllen V Stevens, Mark Raffeld, Virginia Espina, et al.
Nature Reviews. Disease Primers|March 5, 2026
Ovarian cancerClare L Scott, Susana Banerjee, Florence Joly, et al.
Bio Systems|March 13, 2002
Robustness of MetaNet graph models: predicting control of urea production in humansMichael C Kohn, Abdul S Tohmaz, Karen J Giroux, et al.
Anticancer Research|November 3, 2004
Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2Frank G E Perabo, Andreas Wirger, Stefan Kamp, et al.
Gynecologic Oncology|June 17, 2011
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cellsEbony Hoskins, Jaime Rodriguez-Canales, Stephen M Hewitt, et al.
Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.
Pageof 37

Showing results (231-240 of 369) with videos related to

Sort By:
Pageof 37
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumorsO M El-Badry, C Minniti, E C Kohn, et al.
Cancer Research|February 15, 1994
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAIE C Kohn, C C Felder, W Jacobs, et al.
Proteomics|January 15, 2002
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancerMonica Brown Jones, Henry Krutzsch, Hungjun Shu, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Cancer|April 22, 2005
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinomaEllen V Stevens, Mark Raffeld, Virginia Espina, et al.
Nature Reviews. Disease Primers|March 5, 2026
Ovarian cancerClare L Scott, Susana Banerjee, Florence Joly, et al.
Bio Systems|March 13, 2002
Robustness of MetaNet graph models: predicting control of urea production in humansMichael C Kohn, Abdul S Tohmaz, Karen J Giroux, et al.
Anticancer Research|November 3, 2004
Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2Frank G E Perabo, Andreas Wirger, Stefan Kamp, et al.
Gynecologic Oncology|June 17, 2011
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cellsEbony Hoskins, Jaime Rodriguez-Canales, Stephen M Hewitt, et al.
Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.
Pageof 37